首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1460788

生物樣本庫設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、應用（再生醫學、藥物發現等）、地區和競爭細分，2019-2029F

Biobank Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application (Regenerative Medicine, Drug Discovery, and Others), By Region and Competition, 2019-2029F

出版日期: 2024年04月03日 | 出版商:

TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球生物樣本庫設備市場估值為 472.5 億美元，預計在預測期內將強勁成長，到 2029 年CAGR為5.75%。生物樣本庫設備是指生物樣本（包括組織、細胞）的專門儲存和處理解決方案、DNA 和其他生物分子。這些設施作為重要的儲存庫，為研究人員提供了獲得各種應用所需的各種樣本的機會，例如藥物發現、基因組學和疾病研究。

該市場的主要驅動力之一是全球慢性病盛行率的上升。這推動了對生物樣本庫的需求，生物樣本庫在了解導致這些疾病的潛在遺傳、環境和生活方式因素方面發揮關鍵作用。此外，個人化醫療和基因組研究的出現加劇了對高品質、保存完好的生物樣本的需求。

主要市場促進因素

慢性病盛行率上升

The Global Biobank Equipment Market was valued at USD 47.25 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 5.75% through 2029. Biobank equipment refers to specialized storage and handling solutions for biological samples, including tissues, cells, DNA, and other biomolecules. These facilities serve as crucial repositories, providing researchers with access to a diverse range of specimens for various applications, such as drug discovery, genomics, and disease research.

One of the key drivers of this market is the rising prevalence of chronic diseases worldwide. This has propelled the demand for biobanks, which play a pivotal role in understanding the underlying genetic, environmental, and lifestyle factors contributing to these diseases. Additionally, the emergence of personalized medicine and genomic research is fueling the need for high-quality, well-preserved biological samples.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases has emerged as a significant driver in the growth of the biobank equipment market. With conditions like diabetes, cardiovascular diseases, and various forms of cancer becoming more widespread, there is an imperative need for comprehensive research and development efforts. Biobanks play a pivotal role in this process by providing a repository for storing and managing biological samples essential for understanding the underlying genetic, environmental, and lifestyle factors contributing to these diseases. This surge in demand for biobank facilities has led to a corresponding increase in the need for advanced equipment that can efficiently handle, store, and preserve these precious biological specimens. As a result, manufacturers and suppliers of biobank equipment are experiencing a substantial upswing in their market share, driven by the urgent requirement to combat the rising tide of chronic illnesses through rigorous scientific investigation and targeted therapies.

Increasing Biomedical Research

The expansion of biomedical research has emerged as a powerful catalyst for the growth of the biobank equipment market. As scientific advancements continue to unlock new avenues for understanding and treating various diseases, the demand for high-quality biological samples has surged. Biobanks serve as indispensable repositories for these critical specimens, providing a centralized and organized platform for researchers to access a diverse range of samples. This surge in demand has created a corresponding need for advanced equipment capable of efficiently processing, storing, and managing these biological resources. Manufacturers and suppliers of biobank equipment are thus experiencing a notable uptick in demand. Moreover, as the scope and complexity of biomedical research expand to encompass personalized medicine, genetic studies, and drug development, the importance of biobanks in facilitating these endeavors becomes increasingly apparent. Consequently, the market for biobank equipment is poised for sustained growth, driven by the escalating requirements of the burgeoning biomedical research community worldwide.

Key Market Challenges

Ethical and Legal Issues

Biobanks must navigate a complex landscape of ethical considerations and legal requirements when collecting and storing biological samples. This includes obtaining informed consent from donors, which ensures that individuals are fully aware of how their samples will be used in research and have given their voluntary permission for it.

Additionally, biobanks must address privacy and confidentiality concerns. They need to implement measures to protect the identity and personal information of donors, ensuring that their data remains confidential and secure.

Another crucial aspect is determining ownership and usage rights of stored samples. This involves defining who has control over the samples and under what circumstances they can be used for research. This can be particularly challenging in cases where samples are donated for a specific study but may hold potential for other research projects in the future.

Sample Quality and Integrity

Biobanks are entrusted with the responsibility of preserving biological specimens, such as tissues, cells, and DNA, for potential use in research. However, over time, these samples can face various threats to their integrity. Factors like improper storage conditions, fluctuations in temperature, exposure to contaminants, and natural degradation processes can all compromise the quality of the samples.

To mitigate these risks, biobanks must implement stringent protocols for sample handling, storage, and monitoring. This includes using specialized equipment like ultra-low temperature freezers, cryogenic storage systems, and other advanced technologies to maintain the samples in optimal conditions. Regular monitoring and maintenance of equipment are essential to ensure consistent and reliable storage conditions.

Additionally, biobanks must have contingency plans in place to address potential emergencies or equipment failures that could jeopardize sample integrity. This may involve backup power systems, redundant storage facilities, and protocols for transferring samples in case of emergencies.

Quality control measures, such as periodic sample testing and validation, are also crucial for identifying and addressing any potential issues with sample quality. This helps ensure that the samples retain their integrity and viability for future research purposes.

Key Market Trends

Automation and Robotics Integration

Automation and robotics are being increasingly employed in biobanks to streamline and enhance various processes involved in sample management. This trend is driven by the desire to improve operational efficiency, reduce human error, and optimize resource utilization.

In practical terms, this trend involves the use of automated systems for tasks such as sample retrieval, tracking, labeling, and storage. Advanced robotic systems can handle samples with precision and accuracy, ensuring that they are stored and handled in optimal conditions. This not only minimizes the risk of contamination or degradation but also allows for more efficient use of storage space.

Furthermore, automation can facilitate high-throughput processing, enabling biobanks to handle larger volumes of samples more effectively. This is particularly crucial as the demand for biospecimens in research continues to grow.

Growing Role of Genomic Biobanks

Genomic biobanks focus primarily on the collection, storage, and management of genetic materials, such as DNA, RNA, and other genetic components. These biobanks play a pivotal role in supporting research initiatives that seek to understand and analyse the genetic basis of various diseases, as well as contribute to advancements in personalized medicine.

Genomic biobanks are particularly crucial in the era of genomics, where researchers are increasingly interested in studying the genetic variations that underlie diseases and impact individual responses to treatments. By storing genetic materials from a diverse range of donors, these biobanks provide a rich source of data for genetic studies and help accelerate discoveries in areas like disease susceptibility, drug development, and the development of targeted therapies.

The trend of focusing on genomic biobanking reflects a broader shift in the field of biobanking towards precision medicine. This approach tailor's medical treatment and interventions to the individual characteristics of patients, including their genetic makeup. Genomic biobanks are at the forefront of this trend, supplying the genetic information needed for more personalized and effective healthcare solutions.

Segmental Insights

Application Insights

The Drug Discovery Segment dominates the Biobank Equipment market and is predicted to continue expanding over the coming years.The drug discovery segment is poised to dominate the global biobank equipment market due to its critical role in advancing pharmaceutical research and development. Biobanks serve as invaluable repositories of biological samples, providing researchers with access to a diverse range of specimens for drug testing and development. As the demand for novel and effective pharmaceutical compounds continues to surge, biobanks have become indispensable resources for the biopharmaceutical industry. These facilities store a wide array of biological materials, including tissues, cells, and genetic samples, which are essential for pre-clinical and clinical trials.

Regional Insights

The North America region has established itself as the leader in the Biobank Equipment Market in 2023due to a combination of factors that make it a thriving hub for Biobank Equipment innovation and adoption.The North America region has emerged as the frontrunner in the Biobank Equipment Market in 2023, primarily due to a convergence of factors that position it as a dynamic centre for Biobank Equipment innovation and adoption. Firstly, North America boasts a robust and mature healthcare infrastructure, characterized by advanced research facilities, well-established biotechnology firms, and a highly skilled workforce. This environment fosters a conducive ecosystem for the development and deployment of cutting-edge biobank equipment.

Furthermore, the region is characterized by a strong emphasis on research and development, with substantial investments being made in biomedical sciences and pharmaceuticals. This commitment to scientific advancement drives the demand for state-of-the-art biobank equipment, which plays a pivotal role in facilitating ground-breaking research endeavours.

Key Market Players

Becton, Dickinson and Company

Bio-Techne Corporation

Hamilton Company

Merck KgaA

Lonza Group AG

QIAGEN N.V.

Stemcell Technologies Inc.

Tecan Group AG

Thermo Fisher Scientific Inc

Report Scope:

In this report, the Global Biobank Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biobank Equipment Market, Test Type:

Equipment

Cryogenic Storage System

Alarm Monitoring Systems

Others

Media Consumables

Biobank Equipment Market, End User:

Pharmaceutical and Biotechnology Companies

Medical Device Companies

Others

Biobank Equipment Market, By Region:

North America

United States
Canada
Mexico

Europe

Germany
United Kingdom
Italy
France
Spain

Asia Pacific

China
India
Japan
South Korea
Australia

South America

Brazil
Argentina
Colombia

Middle East Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biobank Equipment Market.

Available Customizations:

Global Biobank Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1.Product Overview

1.1.Market Definition
1.2.Scope of the Market
- 1.2.1.Markets Covered
- 1.2.2.Years Considered for Study
- 1.2.3.Key Market Segmentations

2.Research Methodology

2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validations
2.7.Assumptions and Limitations

3.Executive Summary

3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.GlobalBiobank Equipment MarketOutlook

5.1.Market Size Forecast
- 5.1.1.By Value
5.2.Market Share Forecast
- 5.2.1.By Product {Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others), Media Consumables}
- 5.2.2.By Application (Regenerative Medicine, Drug Discovery, and Others)
- 5.2.3.By Region
- 5.2.4.By Company (2023)
5.3.Market Map

6.North America Biobank Equipment Market Outlook

6.1.Market Size Forecast
- 6.1.1.By Value
6.2.Market Share Forecast
- 6.2.1.By Product
- 6.2.2.By Application
- 6.2.3.By Country
6.3.North America: Country Analysis
- 6.3.1.United States Biobank Equipment Market Outlook
  - 6.3.1.1.Market Size Forecast
    - 6.3.1.1.1.By Value
  - 6.3.1.2.Market Share Forecast
    - 6.3.1.2.1.By Product
    - 6.3.1.2.2.By Application
- 6.3.2.Canada Biobank Equipment Market Outlook
  - 6.3.2.1.Market Size Forecast
    - 6.3.2.1.1.By Value
  - 6.3.2.2.Market Share Forecast
    - 6.3.2.2.1.By Product
    - 6.3.2.2.2.By Application
- 6.3.3.Mexico Biobank Equipment Market Outlook
  - 6.3.3.1.Market Size Forecast
    - 6.3.3.1.1.By Value
  - 6.3.3.2.Market Share Forecast
    - 6.3.3.2.1.By Product
    - 6.3.3.2.2.By Application

7.Europe Biobank Equipment Market Outlook

7.1.Market Size Forecast
- 7.1.1.By Value
7.2.Market Share Forecast
- 7.2.1.By Product
- 7.2.2.By Application
- 7.2.3.By Country
7.3.Europe: Country Analysis
- 7.3.1.Germany Biobank Equipment Market Outlook
  - 7.3.1.1.Market Size Forecast
    - 7.3.1.1.1.By Value
  - 7.3.1.2.Market Share Forecast
    - 7.3.1.2.1.By Product
    - 7.3.1.2.2.By Application
- 7.3.2.United Kingdom Biobank Equipment Market Outlook
  - 7.3.2.1.Market Size Forecast
    - 7.3.2.1.1.By Value
  - 7.3.2.2.Market Share Forecast
    - 7.3.2.2.1.By Product
    - 7.3.2.2.2.By Application
- 7.3.3.Italy Biobank Equipment Market Outlook
  - 7.3.3.1.Market Size Forecast
    - 7.3.3.1.1.By Value
  - 7.3.3.2.Market Share Forecasty
    - 7.3.3.2.1.By Product
    - 7.3.3.2.2.By Application
- 7.3.4.France Biobank Equipment Market Outlook
  - 7.3.4.1.Market Size Forecast
    - 7.3.4.1.1.By Value
  - 7.3.4.2.Market Share Forecast
    - 7.3.4.2.1.By Product
    - 7.3.4.2.2.By Application
- 7.3.5.Spain Biobank Equipment Market Outlook
  - 7.3.5.1.Market Size Forecast
    - 7.3.5.1.1.By Value
  - 7.3.5.2.Market Share Forecast
    - 7.3.5.2.1.By Product
    - 7.3.5.2.2.By Application

8.Asia-Pacific Biobank Equipment Market Outlook

8.1.Market Size Forecast
- 8.1.1.By Value
8.2.Market Share Forecast
- 8.2.1.By Product
- 8.2.2.By Application
- 8.2.3.By Country
8.3.Asia-Pacific: Country Analysis
- 8.3.1.China Biobank Equipment Market Outlook
  - 8.3.1.1.Market Size Forecast
    - 8.3.1.1.1.By Value
  - 8.3.1.2.Market Share Forecast
    - 8.3.1.2.1.By Product
    - 8.3.1.2.2.By Application
- 8.3.2.India Biobank Equipment Market Outlook
  - 8.3.2.1.Market Size Forecast
    - 8.3.2.1.1.By Value
  - 8.3.2.2.Market Share Forecast
    - 8.3.2.2.1.By Product
    - 8.3.2.2.2.By Application
- 8.3.3.Japan Biobank Equipment Market Outlook
  - 8.3.3.1.Market Size Forecast
    - 8.3.3.1.1.By Value
  - 8.3.3.2.Market Share Forecast
    - 8.3.3.2.1.By Product
    - 8.3.3.2.2.By Application
- 8.3.4.South Korea Biobank Equipment Market Outlook
  - 8.3.4.1.Market Size Forecast
    - 8.3.4.1.1.By Value
  - 8.3.4.2.Market Share Forecast
    - 8.3.4.2.1.By Product
    - 8.3.4.2.2.By Application
- 8.3.5.Australia Biobank Equipment Market Outlook
  - 8.3.5.1.Market Size Forecast
    - 8.3.5.1.1.By Value
  - 8.3.5.2.Market Share Forecast
    - 8.3.5.2.1.By Product
    - 8.3.5.2.2.By Application

9.South America Biobank Equipment Market Outlook

9.1.Market Size Forecast
- 9.1.1.By Value
9.2.Market Share Forecast
- 9.2.1.By Product
- 9.2.2.By Application
- 9.2.3.By Country
9.3.South America: Country Analysis
- 9.3.1.Brazil Biobank Equipment Market Outlook
  - 9.3.1.1.Market Size Forecast
    - 9.3.1.1.1.By Value
  - 9.3.1.2.Market Share Forecast
    - 9.3.1.2.1.By Product
    - 9.3.1.2.2.By Application
- 9.3.2.Argentina Biobank Equipment Market Outlook
  - 9.3.2.1.Market Size Forecast
    - 9.3.2.1.1.By Value
  - 9.3.2.2.Market Share Forecast
    - 9.3.2.2.1.By Product
    - 9.3.2.2.2.By Application
- 9.3.3.Colombia Biobank Equipment Market Outlook
  - 9.3.3.1.Market Size Forecast
    - 9.3.3.1.1.By Value
  - 9.3.3.2.Market Share Forecast
    - 9.3.3.2.1.By Product
    - 9.3.3.2.2.By Application

10.Middle East and Africa Biobank Equipment Market Outlook

10.1.Market Size Forecast
- 10.1.1.By Value
10.2.Market Share Forecast
- 10.2.1.By Product
- 10.2.2.By Application
- 10.2.3.By Country
10.3.MEA: Country Analysis
- 10.3.1.South Africa Biobank Equipment Market Outlook
  - 10.3.1.1.Market Size Forecast
    - 10.3.1.1.1.By Value
  - 10.3.1.2.Market Share Forecast
    - 10.3.1.2.1.By Product
    - 10.3.1.2.2.By Application
- 10.3.2.Saudi Arabia Biobank Equipment Market Outlook
  - 10.3.2.1.Market Size Forecast
    - 10.3.2.1.1.By Value
  - 10.3.2.2.Market Share Forecast
    - 10.3.2.2.1.By Product
    - 10.3.2.2.2.By Application
- 10.3.3.UAE Biobank Equipment Market Outlook
  - 10.3.3.1.Market Size Forecast
    - 10.3.3.1.1.By Value
  - 10.3.3.2.Market Share Forecast
    - 10.3.3.2.1.By Product
    - 10.3.3.2.2.By Application

11.Market Dynamics

11.1.Drivers
11.2.Challenges

12.Market Trends Developments

12.1.Recent Development
12.2.Mergers Acquisitions

13.Global Biobank Equipment Market: SWOT Analysis

14.Porter's Five Forces Analysis

14.1.Competition in the Industry
14.2.Potential of New Entrants
14.3.Power of Suppliers
14.4.Power of Customers
14.5.Threat of Substitute Treatment Types

15.Competitive Landscape

15.1.Becton, Dickinson and Company
- 15.1.1.Business Overview
- 15.1.2.Service Offerings
- 15.1.3.Recent Developments
- 15.1.4.Key Personnel
- 15.1.5.SWOT Analysis
15.2.Bio-Techne Corporation
15.3.Hamilton Company
15.4.Merck KgaA
15.5.Lonza Group AG
15.6.QIAGEN N.V.
15.7.Stemcell Technologies Inc.
15.8.Tecan Group AG
15.9.Thermo Fisher Scientific Inc